Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality
The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator
Key Issues to Consider with GLP-1 Medications 1
iv therapy
Rare but notable risks include pancreatitis, gallbladder events, and a theoretical concern regarding thyroid C-cell tumors observed in animal studies
US$ 27.32
US$ 23.36
US$ 21.27
US$ 26.23
US$ 26.85
US$ 27.15
US$ 23.45
US$ 23.66
US$ 24.67
US$ 24.24
US$ 26.96
